Cubist Pharmaceuticals (CBST)
|
43.51
+0.43 (+1.00%)
|
|
|
|
CBST analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
CBST price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
CBST earnings
Date
Actual
Expected
Prev Yr Qtr
10/18/2012
0.59
0.46
0.33
7/19/2012
0.58
0.45
-0.34
4/18/2012
0.49
0.44
0.34
Cubist Pharmaceuticals (CBST) Upgrades
Date
Analyst
Old Rating
New Rating
05/28/2010
Cowen & Co
Neutral
Outperform
04/12/2010
Leerink Swann
Underperform
Market Perform
12/03/2009
RBC Capital
Sector Perform
Outperform
07/19/2007
Lazard Capital
Sell
Hold
09/30/2005
RBC
Outperform
N/ A
Cubist Pharmaceuticals (CBST) Downgrades
Date
Analyst
Old Rating
New Rating
12/05/2008
Oppenheimer
Perform
Underperform
11/06/2008
RBC Capital
Outpeform
Sector Perform
03/14/2008
Thomas Weisel
Overweight
Marketweight
01/25/2007
JMP Securities
Market Outperform
Strong Buy
12/08/2006
Piper Jaffray
Market Perform
Outperform
05/31/2006
Lazard Capital Markets
Sell
Hold
Cubist Pharmaceuticals (CBST) New Coverage
Date
Analyst
Rating
11/09/2012
Mizuho Securities
Neutral
10/25/2012
Cantor Fitzgerald
Sell
10/04/2012
Morgan Stanley
Overweight
08/08/2012
Goldman Sachs
Conviction Buy
08/01/2012
Suntrust Robinson Humphrey
Neutral
03/23/2012
ThinkEquity
Buy
